This surface packages investment what-if planning into board-readable routes and JSON outputs.
/scenario-lane keeps owners, audiences, and directions readable./capital-options compares need, savings, upside, and downside./timing-risks shows urgency, confidence, and timing pressure./api/payload exposes the reproducible scenario packet.{
"generatedAt": "2026-06-01T00:00:00Z",
"summary": {
"items": 7,
"averageExposureScore": 52,
"averageSavingsUnlock": 60,
"averageInvestmentNeed": 66,
"averageConfidence": 79,
"averageUrgency": 70,
"averageUpside": 75,
"averageDownside": 47,
"accelerateNowTracks": 3,
"deferTracks": 1,
"committeeCapitalAtRiskMillions": 465,
"highFindings": 1,
"recommendation": "Accelerate AI, revenue, and biotech where upside is already proven, resequence identity and procurement around reusable proof, and defer public-sector expansion until readiness ownership is explicit."
},
"scenarioLane": [
{
"owner": "AI operating partner",
"audience": "Board strategy committee",
"direction": "ACCELERATE",
"scenarioTheme": "Accelerate governed AI positioning",
"boardQuestion": "Should we accelerate AI governance investment now while the platform lead is already visible?",
"scenarioMove": "Accelerate the board-ready AI package and use it as a flagship wedge into diligence and investor conversations.",
"nextCommitteeDecision": "Approve the AI acceleration scenario and fund the board-ready packaging sprint as a top-quartile strategic advantage play."
},
{
"owner": "Security operating lead",
"audience": "Risk committee",
"direction": "RESEQUENCE",
"scenarioTheme": "Resequence identity work around proof reuse",
"boardQuestion": "Can we resequence identity spending to reduce risk faster without opening a proof gap?",
"scenarioMove": "Resequence identity investment around one evidence ledger and one remediation sequence instead of multiple parallel ownership tracks.",
"nextCommitteeDecision": "Resequence identity capital into a single risk-evidence path that closes remediation ambiguity before adding net-new tooling."
},
{
"owner": "Revenue systems partner",
"audience": "Operating committee",
"direction": "ACCELERATE",
"scenarioTheme": "Accelerate margin recovery through infrastructure clarity",
"boardQuestion": "Where should we invest first if the goal is immediate margin recovery without revenue-story drift?",
"scenarioMove": "Accelerate the highest-savings revenue infrastructure lane and defer lower-conviction dashboard work.",
"nextCommitteeDecision": "Fund the top revenue margin-recovery lane now and defer lower-yield reporting enhancements into the next operating cycle."
},
{
"owner": "FinTech diligence lead",
"audience": "Investor diligence committee",
"direction": "HOLD",
"scenarioTheme": "Hold FinTech spend until reserve and review stories converge",
"boardQuestion": "Should we keep funding FinTech controls now, or wait until the reserve, KYC, and merchant-review story is tighter?",
"scenarioMove": "Hold net-new FinTech expansion while consolidating the diligence packet and the backlog story into one investor-facing sequence.",
"nextCommitteeDecision": "Hold discretionary FinTech expansion and finish the integrated diligence packet before the next board or financing cycle."
},
{
"owner": "Quality systems sponsor",
"audience": "Regulated growth committee",
"direction": "ACCELERATE",
"scenarioTheme": "Accelerate regulated-quality flagship packaging",
"boardQuestion": "Should the biotech lane be elevated as a flagship growth-quality system now that the surface is coherent?",
"scenarioMove": "Accelerate the regulated flagship story and use it to justify narrower, better-ranked quality investments.",
"nextCommitteeDecision": "Accelerate the flagship biotech narrative and approve only the narrow follow-on investments that increase evidence density."
},
{
"owner": "Procurement intelligence lead",
"audience": "Go-to-market committee",
"direction": "RESEQUENCE",
"scenarioTheme": "Resequence enterprise-deal proof around reuse",
"boardQuestion": "Where can procurement proof be resequenced to cut deal drag before adding more tooling?",
"scenarioMove": "Resequence the buyer-proof workflow around trust reuse and answer-pack compounding before funding another standalone surface.",
"nextCommitteeDecision": "Resequence procurement work toward trust reuse and answer-pack standardization before approving net-new deal-support tooling."
},
{
"owner": "Public-sector diligence sponsor",
"audience": "Investment committee",
"direction": "DEFER",
"scenarioTheme": "Defer public-sector expansion until readiness ownership is explicit",
"boardQuestion": "Should public-sector expansion be deferred until the disclosure and procurement packet has a named owner?",
"scenarioMove": "Defer expansion and direct near-term energy into one owned readiness pack that can support future sector entry cleanly.",
"nextCommitteeDecision": "Defer broader public-sector expansion and assign one owner to produce a complete readiness packet before the next strategy review."
}
],
"capitalOptions": [
{
"owner": "AI operating partner",
"audience": "Board strategy committee",
"scenarioTheme": "Accelerate governed AI positioning",
"investmentNeedScore": 77,
"savingsUnlockScore": 63,
"upsideScore": 88,
"downsideScore": 34,
"companyTags": [
"IBM",
"Azure",
"OpenAI",
"MCP"
]
},
{
"owner": "Security operating lead",
"audience": "Risk committee",
"scenarioTheme": "Resequence identity work around proof reuse",
"investmentNeedScore": 69,
"savingsUnlockScore": 72,
"upsideScore": 74,
"downsideScore": 57,
"companyTags": [
"CyberArk",
"Okta",
"Entra",
"Intune"
]
},
{
"owner": "Revenue systems partner",
"audience": "Operating committee",
"scenarioTheme": "Accelerate margin recovery through infrastructure clarity",
"investmentNeedScore": 73,
"savingsUnlockScore": 86,
"upsideScore": 87,
"downsideScore": 41,
"companyTags": [
"Klaviyo",
"VWO",
"Power BI",
"Tableau"
]
},
{
"owner": "FinTech diligence lead",
"audience": "Investor diligence committee",
"scenarioTheme": "Hold FinTech spend until reserve and review stories converge",
"investmentNeedScore": 66,
"savingsUnlockScore": 47,
"upsideScore": 62,
"downsideScore": 54,
"companyTags": [
"Payments",
"Treasury",
"KYC",
"Merchant risk"
]
},
{
"owner": "Quality systems sponsor",
"audience": "Regulated growth committee",
"scenarioTheme": "Accelerate regulated-quality flagship packaging",
"investmentNeedScore": 61,
"savingsUnlockScore": 42,
"upsideScore": 84,
"downsideScore": 29,
"companyTags": [
"GxP",
"CAPA",
"Specimen",
"Safety"
]
},
{
"owner": "Procurement intelligence lead",
"audience": "Go-to-market committee",
"scenarioTheme": "Resequence enterprise-deal proof around reuse",
"investmentNeedScore": 58,
"savingsUnlockScore": 81,
"upsideScore": 79,
"downsideScore": 46,
"companyTags": [
"Procurement",
"Trust center",
"Questionnaires",
"RFP"
]
},
{
"owner": "Public-sector diligence sponsor",
"audience": "Investment committee",
"scenarioTheme": "Defer public-sector expansion until readiness ownership is explicit",
"investmentNeedScore": 57,
"savingsUnlockScore": 26,
"upsideScore": 51,
"downsideScore": 71,
"companyTags": [
"GovTech",
"Disclosure",
"Procurement",
"Readiness"
]
}
],
"timingRisks": [
{
"owner": "AI operating partner",
"audience": "Board strategy committee",
"urgencyScore": 58,
"confidenceScore": 91,
"currentPosture": "The governance and agent-readiness lane already reads as a defensible advantage relative to peer operators.",
"scenarioHeadline": "Accelerating AI governance now compounds a visible lead while the evidence base is already strong.",
"relatedSurfaces": [
"watsonx.kineticgain.com",
"scorecard.kineticgain.com",
"memo.kineticgain.com"
],
"requiredEvidence": [
"AI readiness scorecard",
"Governance registry",
"Protocol suite",
"Board narrative memo"
]
},
{
"owner": "Security operating lead",
"audience": "Risk committee",
"urgencyScore": 84,
"confidenceScore": 79,
"currentPosture": "Identity controls are credible, but the value is still split across access review, endpoint proof, and remediation ownership.",
"scenarioHeadline": "Identity does not need more disconnected investment; it needs a tighter sequence that compounds proof.",
"relatedSurfaces": [
"identity.kineticgain.com",
"protect.kineticgain.com",
"crossrisk.kineticgain.com"
],
"requiredEvidence": [
"Identity risk evidence ledger",
"App protection posture",
"Access ownership map",
"Remediation queue"
]
},
{
"owner": "Revenue systems partner",
"audience": "Operating committee",
"urgencyScore": 71,
"confidenceScore": 83,
"currentPosture": "Revenue surfaces already show attribution, reporting, and experiment discipline, but capital allocation is still spread too evenly.",
"scenarioHeadline": "Revenue infrastructure should be accelerated where it converts directly into margin, not everywhere at once.",
"relatedSurfaces": [
"revenue.kineticgain.com",
"martech.kineticgain.com",
"leak.kineticgain.com"
],
"requiredEvidence": [
"Platform margin leak report",
"Revenue infrastructure scorecard",
"Experiment proof",
"Board memo"
]
},
{
"owner": "FinTech diligence lead",
"audience": "Investor diligence committee",
"urgencyScore": 68,
"confidenceScore": 76,
"currentPosture": "The FinTech lane is visible and credible, but the strongest investor story still depends on cleaner reserve-gap and review-throughput packaging.",
"scenarioHeadline": "Holding FinTech expansion briefly can improve the narrative quality of the next investor review without losing core readiness.",
"relatedSurfaces": [
"payments.kineticgain.com",
"treasury.kineticgain.com",
"merchant.kineticgain.com"
],
"requiredEvidence": [
"Investor diligence pack",
"Treasury signal lab",
"KYC queue",
"Merchant review posture"
]
},
{
"owner": "Quality systems sponsor",
"audience": "Regulated growth committee",
"urgencyScore": 52,
"confidenceScore": 90,
"currentPosture": "GxP, CAPA, specimen, safety, and narrative review now read as one coherent system rather than scattered quality tools.",
"scenarioHeadline": "Biotech is ready to be framed as a flagship quality system, not just a set of compliance-adjacent tools.",
"relatedSurfaces": [
"gxp.kineticgain.com",
"capa.kineticgain.com",
"specimen.kineticgain.com"
],
"requiredEvidence": [
"Change control board",
"CAPA ledger",
"Specimen custody console",
"Safety signal router"
]
},
{
"owner": "Procurement intelligence lead",
"audience": "Go-to-market committee",
"urgencyScore": 76,
"confidenceScore": 78,
"currentPosture": "Questionnaires, trust evidence, RFP packaging, and proof-gap scoring are all live, but the reuse story still needs more sequence discipline.",
"scenarioHeadline": "Procurement is a resequencing problem first: the next gain comes from reuse and answer compounding, not new surface area.",
"relatedSurfaces": [
"procurement.kineticgain.com",
"questionnaire.kineticgain.com",
"proofgap.kineticgain.com"
],
"requiredEvidence": [
"Procurement ready OS",
"Questionnaire answer studio",
"Trust center evidence room",
"Vendor proof gap monitor"
]
},
{
"owner": "Public-sector diligence sponsor",
"audience": "Investment committee",
"urgencyScore": 82,
"confidenceScore": 59,
"currentPosture": "There is visible public-sector potential, but the readiness story is still too under-owned to justify broader outward claims.",
"scenarioHeadline": "Public-sector should be deferred until the readiness packet exists, even if the strategic pull is real.",
"relatedSurfaces": [
"procurement.kineticgain.com",
"claims.kineticgain.com",
"memo.kineticgain.com"
],
"requiredEvidence": [
"Public-sector readiness memo",
"Disclosure pack",
"Owner map",
"Procurement storyline",
"Board review summary"
]
}
],
"riskMap": [
{
"code": "thin-scenario-proof",
"severity": "high",
"track": "PUBLIC_SECTOR",
"audience": "Investment committee",
"message": "The scenario recommendation is still resting on thin proof, which weakens the committee packet."
},
{
"code": "defer-with-risk",
"severity": "medium",
"track": "PUBLIC_SECTOR",
"audience": "Investment committee",
"message": "This scenario is being deferred despite material exposure, so the board story needs a clearer risk acceptance case."
},
{
"code": "resequence-savings",
"severity": "medium",
"track": "REVENUE_SYSTEMS",
"audience": "Operating committee",
"message": "This lane has enough savings potential that leadership should consider resequencing the investment path."
},
{
"code": "accelerate-now",
"severity": "info",
"track": "AI_PLATFORM",
"audience": "Board strategy committee",
"message": "This scenario is already strong enough to support an immediate acceleration recommendation."
},
{
"code": "accelerate-now",
"severity": "info",
"track": "REVENUE_SYSTEMS",
"audience": "Operating committee",
"message": "This scenario is already strong enough to support an immediate acceleration recommendation."
},
{
"code": "accelerate-now",
"severity": "info",
"track": "BIOTECH_DIAGNOSTICS",
"audience": "Regulated growth committee",
"message": "This scenario is already strong enough to support an immediate acceleration recommendation."
}
],
"verification": [
"Synthetic scenario data only - no live board decisions, capital plans, or internal committee materials are included.",
"Exposure, savings unlock, investment need, upside, downside, and urgency metrics are modeled from the sample executive-intelligence set in this repo.",
"This surface is read-only and designed to show how Kinetic Gain can package investment-committee what-if scenarios into one board-readable operating layer.",
"Company tags and track labels are synthetic design aids rather than audited market signals.",
"Every route and packet is reproducible from the included sample export."
],
"sample": [
{
"id": "ai-committee-accelerate",
"owner": "AI operating partner",
"audience": "Board strategy committee",
"track": "AI_PLATFORM",
"direction": "ACCELERATE",
"scenarioTheme": "Accelerate governed AI positioning",
"boardQuestion": "Should we accelerate AI governance investment now while the platform lead is already visible?",
"currentPosture": "The governance and agent-readiness lane already reads as a defensible advantage relative to peer operators.",
"scenarioMove": "Accelerate the board-ready AI package and use it as a flagship wedge into diligence and investor conversations.",
"exposureScore": 31,
"savingsUnlockScore": 63,
"investmentNeedScore": 77,
"confidenceScore": 91,
"urgencyScore": 58,
"upsideScore": 88,
"downsideScore": 34,
"scenarioHeadline": "Accelerating AI governance now compounds a visible lead while the evidence base is already strong.",
"scenarioNarrative": "The capital case is not speculative model spend. It is accelerating a governance and procurement surface that already converts technical work into executive trust.",
"nextCommitteeDecision": "Approve the AI acceleration scenario and fund the board-ready packaging sprint as a top-quartile strategic advantage play.",
"companyTags": [
"IBM",
"Azure",
"OpenAI",
"MCP"
],
"relatedSurfaces": [
"watsonx.kineticgain.com",
"scorecard.kineticgain.com",
"memo.kineticgain.com"
],
"requiredEvidence": [
"AI readiness scorecard",
"Governance registry",
"Protocol suite",
"Board narrative memo"
]
},
{
"id": "identity-committee-resequence",
"owner": "Security operating lead",
"audience": "Risk committee",
"track": "IDENTITY_SECURITY",
"direction": "RESEQUENCE",
"scenarioTheme": "Resequence identity work around proof reuse",
"boardQuestion": "Can we resequence identity spending to reduce risk faster without opening a proof gap?",
"currentPosture": "Identity controls are credible, but the value is still split across access review, endpoint proof, and remediation ownership.",
"scenarioMove": "Resequence identity investment around one evidence ledger and one remediation sequence instead of multiple parallel ownership tracks.",
"exposureScore": 67,
"savingsUnlockScore": 72,
"investmentNeedScore": 69,
"confidenceScore": 79,
"urgencyScore": 84,
"upsideScore": 74,
"downsideScore": 57,
"scenarioHeadline": "Identity does not need more disconnected investment; it needs a tighter sequence that compounds proof.",
"scenarioNarrative": "The committee decision is strongest when identity spend is framed as a sequence problem, not a tool-count problem.",
"nextCommitteeDecision": "Resequence identity capital into a single risk-evidence path that closes remediation ambiguity before adding net-new tooling.",
"companyTags": [
"CyberArk",
"Okta",
"Entra",
"Intune"
],
"relatedSurfaces": [
"identity.kineticgain.com",
"protect.kineticgain.com",
"crossrisk.kineticgain.com"
],
"requiredEvidence": [
"Identity risk evidence ledger",
"App protection posture",
"Access ownership map",
"Remediation queue"
]
},
{
"id": "revenue-committee-accelerate",
"owner": "Revenue systems partner",
"audience": "Operating committee",
"track": "REVENUE_SYSTEMS",
"direction": "ACCELERATE",
"scenarioTheme": "Accelerate margin recovery through infrastructure clarity",
"boardQuestion": "Where should we invest first if the goal is immediate margin recovery without revenue-story drift?",
"currentPosture": "Revenue surfaces already show attribution, reporting, and experiment discipline, but capital allocation is still spread too evenly.",
"scenarioMove": "Accelerate the highest-savings revenue infrastructure lane and defer lower-conviction dashboard work.",
"exposureScore": 49,
"savingsUnlockScore": 86,
"investmentNeedScore": 73,
"confidenceScore": 83,
"urgencyScore": 71,
"upsideScore": 87,
"downsideScore": 41,
"scenarioHeadline": "Revenue infrastructure should be accelerated where it converts directly into margin, not everywhere at once.",
"scenarioNarrative": "The investment case lands when savings sequencing is explicit enough for finance to defend, not merely interesting for ops to explore.",
"nextCommitteeDecision": "Fund the top revenue margin-recovery lane now and defer lower-yield reporting enhancements into the next operating cycle.",
"companyTags": [
"Klaviyo",
"VWO",
"Power BI",
"Tableau"
],
"relatedSurfaces": [
"revenue.kineticgain.com",
"martech.kineticgain.com",
"leak.kineticgain.com"
],
"requiredEvidence": [
"Platform margin leak report",
"Revenue infrastructure scorecard",
"Experiment proof",
"Board memo"
]
},
{
"id": "fintech-committee-hold",
"owner": "FinTech diligence lead",
"audience": "Investor diligence committee",
"track": "FINTECH",
"direction": "HOLD",
"scenarioTheme": "Hold FinTech spend until reserve and review stories converge",
"boardQuestion": "Should we keep funding FinTech controls now, or wait until the reserve, KYC, and merchant-review story is tighter?",
"currentPosture": "The FinTech lane is visible and credible, but the strongest investor story still depends on cleaner reserve-gap and review-throughput packaging.",
"scenarioMove": "Hold net-new FinTech expansion while consolidating the diligence packet and the backlog story into one investor-facing sequence.",
"exposureScore": 58,
"savingsUnlockScore": 47,
"investmentNeedScore": 66,
"confidenceScore": 76,
"urgencyScore": 68,
"upsideScore": 62,
"downsideScore": 54,
"scenarioHeadline": "Holding FinTech expansion briefly can improve the narrative quality of the next investor review without losing core readiness.",
"scenarioNarrative": "The strongest decision may be to pause new expansion work until the diligence pack and operating metrics can tell the same story.",
"nextCommitteeDecision": "Hold discretionary FinTech expansion and finish the integrated diligence packet before the next board or financing cycle.",
"companyTags": [
"Payments",
"Treasury",
"KYC",
"Merchant risk"
],
"relatedSurfaces": [
"payments.kineticgain.com",
"treasury.kineticgain.com",
"merchant.kineticgain.com"
],
"requiredEvidence": [
"Investor diligence pack",
"Treasury signal lab",
"KYC queue",
"Merchant review posture"
]
},
{
"id": "biotech-committee-accelerate",
"owner": "Quality systems sponsor",
"audience": "Regulated growth committee",
"track": "BIOTECH_DIAGNOSTICS",
"direction": "ACCELERATE",
"scenarioTheme": "Accelerate regulated-quality flagship packaging",
"boardQuestion": "Should the biotech lane be elevated as a flagship growth-quality system now that the surface is coherent?",
"currentPosture": "GxP, CAPA, specimen, safety, and narrative review now read as one coherent system rather than scattered quality tools.",
"scenarioMove": "Accelerate the regulated flagship story and use it to justify narrower, better-ranked quality investments.",
"exposureScore": 36,
"savingsUnlockScore": 42,
"investmentNeedScore": 61,
"confidenceScore": 90,
"urgencyScore": 52,
"upsideScore": 84,
"downsideScore": 29,
"scenarioHeadline": "Biotech is ready to be framed as a flagship quality system, not just a set of compliance-adjacent tools.",
"scenarioNarrative": "The committee case is strongest when the lane is treated as a growth-enabling quality system with tight incremental funding, not as defensive overhead.",
"nextCommitteeDecision": "Accelerate the flagship biotech narrative and approve only the narrow follow-on investments that increase evidence density.",
"companyTags": [
"GxP",
"CAPA",
"Specimen",
"Safety"
],
"relatedSurfaces": [
"gxp.kineticgain.com",
"capa.kineticgain.com",
"specimen.kineticgain.com"
],
"requiredEvidence": [
"Change control board",
"CAPA ledger",
"Specimen custody console",
"Safety signal router"
]
},
{
"id": "procurement-committee-resequence",
"owner": "Procurement intelligence lead",
"audience": "Go-to-market committee",
"track": "PROCUREMENT_TRUST",
"direction": "RESEQUENCE",
"scenarioTheme": "Resequence enterprise-deal proof around reuse",
"boardQuestion": "Where can procurement proof be resequenced to cut deal drag before adding more tooling?",
"currentPosture": "Questionnaires, trust evidence, RFP packaging, and proof-gap scoring are all live, but the reuse story still needs more sequence discipline.",
"scenarioMove": "Resequence the buyer-proof workflow around trust reuse and answer-pack compounding before funding another standalone surface.",
"exposureScore": 53,
"savingsUnlockScore": 81,
"investmentNeedScore": 58,
"confidenceScore": 78,
"urgencyScore": 76,
"upsideScore": 79,
"downsideScore": 46,
"scenarioHeadline": "Procurement is a resequencing problem first: the next gain comes from reuse and answer compounding, not new surface area.",
"scenarioNarrative": "The committee should treat procurement drag as a systems-sequencing issue, because the evidence assets now exist but are still under-compounded.",
"nextCommitteeDecision": "Resequence procurement work toward trust reuse and answer-pack standardization before approving net-new deal-support tooling.",
"companyTags": [
"Procurement",
"Trust center",
"Questionnaires",
"RFP"
],
"relatedSurfaces": [
"procurement.kineticgain.com",
"questionnaire.kineticgain.com",
"proofgap.kineticgain.com"
],
"requiredEvidence": [
"Procurement ready OS",
"Questionnaire answer studio",
"Trust center evidence room",
"Vendor proof gap monitor"
]
},
{
"id": "public-sector-committee-defer",
"owner": "Public-sector diligence sponsor",
"audience": "Investment committee",
"track": "PUBLIC_SECTOR",
"direction": "DEFER",
"scenarioTheme": "Defer public-sector expansion until readiness ownership is explicit",
"boardQuestion": "Should public-sector expansion be deferred until the disclosure and procurement packet has a named owner?",
"currentPosture": "There is visible public-sector potential, but the readiness story is still too under-owned to justify broader outward claims.",
"scenarioMove": "Defer expansion and direct near-term energy into one owned readiness pack that can support future sector entry cleanly.",
"exposureScore": 73,
"savingsUnlockScore": 26,
"investmentNeedScore": 57,
"confidenceScore": 59,
"urgencyScore": 82,
"upsideScore": 51,
"downsideScore": 71,
"scenarioHeadline": "Public-sector should be deferred until the readiness packet exists, even if the strategic pull is real.",
"scenarioNarrative": "The disciplined move is not to over-claim. It is to delay expansion until one owner can defend the disclosure, procurement, and suitability story end to end.",
"nextCommitteeDecision": "Defer broader public-sector expansion and assign one owner to produce a complete readiness packet before the next strategy review.",
"companyTags": [
"GovTech",
"Disclosure",
"Procurement",
"Readiness"
],
"relatedSurfaces": [
"procurement.kineticgain.com",
"claims.kineticgain.com",
"memo.kineticgain.com"
],
"requiredEvidence": [
"Public-sector readiness memo",
"Disclosure pack",
"Owner map",
"Procurement storyline",
"Board review summary"
]
}
]
}